July 12, 2019

Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting

July 12, 2019
BOSTON–(BUSINESS WIRE)–Jul. 12, 2019– Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with Salarius Pharmaceuticals, LLC at Flex Pharma’s special meeting of stockholders. Flex Pharma will file a Form 8-K to disclose detailed voting results for each proposal. Flex Pharma expects to complete the merger within the next week or two.


Jeremy Feffer LifeSci Advisors, Managing Director
Download PDF